AstraZeneca moves to own multimodal oncology AI with Modella
1. AstraZeneca is acquiring Modella AI to embed multimodal foundation models into oncology R&D and strengthen biomarker driven trial strategy. ...
1. AstraZeneca is acquiring Modella AI to embed multimodal foundation models into oncology R&D and strengthen biomarker driven trial strategy. ...
In the emergency department, timely and effective relief from migraine headaches is a clinical priority. Multiple medications are available, used ...
The Scan by 2 Minute Medicine® is a pop-culture medical newsletter and exclusive benefit for 2 Minute Medicine Plus subscribers. Venus ...
mRNA SARS-CoV-2 Vaccination Before vs During Pregnancy and Omicron Infection Among Infants 1. In a retrospective cohort of Singaporean, maternal ...
1. In a retrospective study from a large US health database, use of drugs from several different categories, including tricyclic ...
1. In this cross-sectional study, the use of medications with depression as an adverse effect was associated with a higher ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.